Recilisib
Recilisib (ON 01210) is a small molecule radioprotectant that functions by activating the PI3K/AKT signaling pathway. It has demonstrated protective effects in cellular (in vitro) and animal (in vivo) models against radiation-induced damage, supporting its research in radiation biology and oncology.
Product Specifications
CAS Number
334969-03-8
Product Name Alternative
Recilisib, PI3K, PKB, Protein kinase B, Phosphoinositide 3-kinase, ON01210, ON-01210, ON 01210, inhibit, Inhibitor, Ex-RAD, Akt
Field of Research
Signal Transduction
Purity
98.85% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:2.5 mg/mL (7.42 mM) ; DMSO:50 mg/mL (148.46 mM)
Smiles
OC (=O) c1ccc (\C=C\S (=O) (=O) Cc2ccc (Cl) cc2) cc1
Molecular Formula
C16H13ClO4S
Molecular Weight
336.79
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1237704 1.0 µg DNA
LRRC66 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
ARP48856_P050 100 µL
PDSS2 antibody - C-terminal region (ARP48856_P050)
Sign In for Pricing
View Details 